Breast Implant News and Research

RSS

Breast implant rupture risk scrutinized and assessed in depth

According to Tim Goodacre, one of the members of the government-commissioned panel investigating the PIP breast implant scandal, the rupture rates found by the country’s biggest cosmetic surgery company were ‘unacceptable’. Mr. Goodacre, president of the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) and an Oxford University lecturer, said that if the panel confirmed the findings – in which almost one in 14 implants had leaked – then they should all be taken out in every case.

2 Jan 2012

Venezuela offers to pay for removal of faulty breast implants

Venezuela's government has offered to pay for the removal of PIP breast implants feared to be at risk of rupture. They would cover the cost of the surgery for Venezuelan women but would not pay for replacement implants, Health Minister Eugenia Sader said. Ms Sader said many implants made by French firm Poly Implant Prothese (PIP) had been imported illegally.

29 Dec 2011

Faulty PIP breast implant fears deepen

After the scare that some French breast implants may be faulty and may need removal at the government's expense the national health insurance agency will file a criminal complaint. The implants, made by now-defunct French company Poly Implant Prothese (PIP), were pulled from the market last year in countries around Europe and South America amid fears they could rupture and leak silicone into the body.

28 Dec 2011

Allergan seeks to reassure surgeons, patients about safety of breast implants

Allergan, Inc. seeks to reassure patients and surgeons around the world utilizing Allergan's breast implant devices that its products are not part of the recent investigation into breast implant devices manufactured by French manufacturer, Poly Implant Prosthese (PIP) by regulatory authorities in Europe.

26 Dec 2011

Fear of cancer spurs breast implant recall

There are concerns regarding breast implants and the association with cancer. UP to 30,000 French women and perhaps tens of thousands more around the world may need to have defective breast implants removed after several suspicious cancer cases. The final decision on recall of the implants, produced by the Poly Implant Prothese (PIP) company will be made by the end of the week, after a report from France's National Cancer Institute on December 23.

21 Dec 2011

Pacira announces data from EXPAREL clinical study presented at ASPS 2011 meeting

Pacira Pharmaceuticals, Inc. today announced that the company's lead investigational product for postsurgical pain management, EXPAREL, was highlighted in the "Hot Topics in Plastic Surgery" panel at the annual scientific assembly of the American Society of Plastic Surgeons (ASPS) in Denver, Colo.

26 Sep 2011

FDA panel on post-approval studies of silicone breast implants

A panel of expert advisors to the FDA has been asked to look into the matter of the thousands of women who enrolled in studies designed to evaluate rare complications that might arise years after they received silicone gel breast implants.

31 Aug 2011

Silicone gel-filled breast implants: FDA releases updated data

The U.S. Food and Drug Administration released a report today updating the clinical and scientific information for silicone gel-filled breast implants, including preliminary safety data from studies conducted by the manufacturers as a condition of their November 2006 approval.

23 Jun 2011

Silicone-gel breast implant complications to be watched out for: FDA

The U.S. Food and Drug Administration (FDA) said Wednesday that women receiving silicone-gel breast implants have frequent complications like scarring or hardening breasts, and 20% or more of patients required implant removal within 10 years.

23 Jun 2011

Keller Medical's silicone breast implant delivery device receives European CE Mark approval

Keller Medical, Inc., a privately held company, announced today that it has received CE approval for the Keller Funnel gel implant delivery device.

6 May 2011

New findings show relation between breast implants and anaplastic large cell lymphoma

Breast implants appear to be associated with a rare form of lymphoma, but there is not yet evidence to show that the cancer is caused by implants or to suggest an underlying mechanism for how the disease might develop, according to a study by researchers from the RAND Corporation.

20 Apr 2011

FDA reports possible association between breast implants, ALCL

The U.S. Food and Drug Administration reported on January 26 that "a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer. Data reviewed by the FDA suggests that patients with breast implants may have a very small, but significant risk, of ALCL in the scar capsule adjacent to the implant.

29 Jan 2011

U.S. FDA announces link between breast implants and ALCL

The U.S. Food and Drug Administration today announced a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer.

27 Jan 2011

ASPS, FDA collaborate to establish national breast implant registry

The American Society of Plastic Surgeons (ASPS) is establishing a national registry for breast implants in collaboration with the Food and Drug Administration (FDA). The registry is being developed in response to reports of a rare lymphoma--Anaplastic Large Cell Lymphoma (ALCL)—in a very small number of women with breast implants.

27 Jan 2011

URMC's Cone Beam CT scanner studies presented at RSNA 2010

While questions persist about the best ways to detect breast cancer early, a CT imaging system developed at the University of Rochester Medical Center and first unveiled five years ago is in a better position today to enter the fray -- at least in a supporting role to conventional mammography.

4 Dec 2010

Allergan third quarter diluted loss per share increases to $2.21

Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.

1 Nov 2010

Upward trend for post-breast feeding breast augmentation procedures

The Harley Medical Group, Ireland's leading cosmetic surgery provider, has revealed breast surgery is top of the ops for the 23rd year running and the fastest growing sector of cosmetic surgery. The Harley Medical Group has seen a positive increase on last year's enquiries. While breast reductions are becoming more popular with an increasing number of Irish women reducing their breast size in order to achieve a more slender figure, breast augmentation continues to be the most popular procedure performed at THMG's Dublin clinic.

11 Oct 2010

Australian women increasingly unhappy with cosmetic surgery outcomes

Cosmetic surgery has always been fraught with unrealistic demands and sometimes legal action in cases of dissatisfactory results. Tens of thousands of cosmetic surgeries are performed each year and the numbers are climbing fast. A new study shows that Australian women who volunteer for cosmetic surgeries often have such unrealistic expectations for the outcomes of the surgeries.

6 Apr 2010

Fear of ruptures spurs recall of silicone breast implants in France

Breast enhancement surgery utilizes implants that are essentially bags containing silicone gel. One of the commonest complications of this procedure is the rupture of these silicone implants that may necessitate a repeat procedure. In a new development the implants made French company Poly Implant Prothese (PIP), have reportedly double the risk of rupturing than other implants. Many breast implants used by Australian women have been recalled overseas for containing unauthorised silicone gel.

5 Apr 2010

Study finds groundbreaking technology in TechniScan's Warm Bath Ultrasound promising

TechniScan, Inc.'s unique whole breast ultrasound technology, which provides a comfortable, radiation-free method for assessment of breast lesions was part of a scientific presentation at the National Consortium of Breast Centers (NCBC) conference in Las Vegas last week.

31 Mar 2010